Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma
Abstract The surgical treatment and transcatheter arterial chemoembolization (TACE) rate of human immunodeficiency virus (HIV)-infected hepatocellular carcinoma (HCC) patients is relatively low in West China. For various reasons, most patients do not receive timely surgical treatment. Upon transfer...
Guardado en:
Autores principales: | Lingxiang Kong, Guo Wei, Tao Lv, Li Jiang, Jian Yang, Yong Zhao, Jiayin Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77c967e597ef46539a7503b7bd2f0f91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Shun Liu, et al.
Publicado: (2021) -
TACE Combined with HIFU Versus
Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study
por: Qiwei Zhang MM, et al.
Publicado: (2021) -
Systemic treatment for hepatocellular carcinoma
por: Manushi Aggarwal, et al.
Publicado: (2018) -
Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma
por: Huaxiang Wang, et al.
Publicado: (2021) -
Evolving therapies in the treatment of hepatocellular carcinoma
por: Hans Christian Spangenberg, et al.
Publicado: (2008)